
GSBD Valuation
Goldman Sachs BDC Inc
- Overview
- Forecast
- Valuation
- Earnings
GSBD Relative Valuation
GSBD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GSBD is overvalued; if below, it's undervalued.
Historical Valuation
Goldman Sachs BDC Inc (GSBD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 5.65 is considered Undervalued compared with the five-year average of 7.81. The fair price of Goldman Sachs BDC Inc (GSBD) is between 14.61 to 19.90 according to relative valuation methord. Compared to the current price of 11.96 USD , Goldman Sachs BDC Inc is Undervalued By 18.18%.
Relative Value
Fair Zone
14.61-19.90
Current Price:11.96
18.18%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.82
P/B
Median3y
0.97
Median5y
1.05
19.73
FCF Yield
Median3y
8.58
Median5y
8.36
Competitors Valuation Multiple
The average P/S ratio for GSBD's competitors is 3.17, providing a benchmark for relative valuation. Goldman Sachs BDC Inc Corp (GSBD) exhibits a P/S ratio of 3.06, which is -3.21% above the industry average. Given its robust revenue growth of -15.26%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap

GSBD.N
Goldman Sachs BDC Inc
3.06
Average P/S: 3.17
-15.26%
1.40B

DMLP.O
Dorchester Minerals LP
Loss
39.33%
1.30B

OCSL.O
Oaktree Specialty Lending Corp
3.21
-132.33%
1.27B

NMFC.O
New Mountain Finance Corp
3.27
-8.07%
1.14B

PFLT.N
PennantPark Floating Rate Capital Ltd
5.46
-32.36%
1.06B

KRP.N
Kimbell Royalty Partners LP
3.98
2.64%
1.59B
People Also Watch

VBTX
Veritex Holdings Inc
32.510
USD
+1.28%

LEG
Leggett & Platt Inc
10.330
USD
+0.78%

VRDN
Viridian Therapeutics Inc
17.280
USD
-1.20%

DYN
Dyne Therapeutics Inc
9.950
USD
+7.68%

ENFN
Enfusion Inc
10.990
USD
-0.37%

BLX
Foreign Trade Bank of Latin America Inc
41.740
USD
-1.04%

SCL
Stepan Co
57.050
USD
+0.67%

SPNS
Sapiens International Corporation NV
28.860
USD
+0.31%

STBA
S&T Bancorp Inc
37.670
USD
-0.72%

ACDC
ProFrac Holding Corp
7.720
USD
-5.74%
FAQ

Is Goldman Sachs BDC Inc (GSBD) currently overvalued or undervalued?
Goldman Sachs BDC Inc (GSBD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 5.65 is considered Undervalued compared with the five-year average of 7.81. The fair price of Goldman Sachs BDC Inc (GSBD) is between 14.61 to 19.90 according to relative valuation methord. Compared to the current price of 11.96 USD , Goldman Sachs BDC Inc is Undervalued By 18.18% .

What is Goldman Sachs BDC Inc (GSBD) fair value?

How does GSBD's valuation metrics compare to the industry average?

What is the current P/B ratio for Goldman Sachs BDC Inc (GSBD) as of Jul 25 2025?

What is the current FCF Yield for Goldman Sachs BDC Inc (GSBD) as of Jul 25 2025?

What is the current Forward P/E ratio for Goldman Sachs BDC Inc (GSBD) as of Jul 25 2025?
